Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study

British Medical Journal

Volumn 321, Issue 7274, 2000, Pages 1440-1444

  Mogensen, C E ^a   Neldam, S ^b   Tikkanen, I ^c   Oren, S ^d   Viskoper, R ^d   Watts, R W ^e   Cooper, M E ^f  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Rodovre Centrum 294   (Denmark)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d BARZILAI MEDICAL CENTER   (Israel)

^e NONE   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; PLACEBO;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT OUTCOME;

EID: 0034627208     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.321.7274.1440     Document Type: Article

References (30)

1. Pathogenesis, prevention and treatment of diabetic nephropathy
2. Randomised controlled trial of long term efficacy of captopril on preservation of kidney function in normotensive patients with insulin dependent diabetes and microalbuminuria
3. Prevention of diabetic renal disease with special reference to microalbuminuria
4. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives
5. Pathways for angiotensin II generation in intact human tissue - Evidence from comparative pharmacological interruption of the renin system
6. Angiotensin receptor antagonists: Focus on losartan
7. Additive effects of losartan and enalapril on blood pressure and plasma active renin
8. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man
9. Candesartan cilexetil - A review of its use in essential hypertension
10. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria
11. Improving the quality of reporting of randomized controlled trials. The CONSORT statement
12. Angiotensin-converting enzyme genotype in children and coronary events in their grandparents
13. The role of angiotensin II and bradykinin in experimental diabetic nephropathy: Functional and structural studies
14. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine
15. Lisinopril - A review of its pharmacology and use in the management of the complications of diabetes mellitus
16. Clinical profile of the novel angiotensin II type I blocker candesartan cilexetil
17. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme - Observational follow up study
18. Nephropathy in type 2 diabetes
19. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes
20. Addition of angiotensin II receptor blockade to maximal angiotensinconverting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure
21. Combination ACE inhibitor and angiotensin II receptor antagonist therapy in diabetic nephropathy
22. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with lgA nephropathy
23. Safety of the combination of valsartan and benazepril in patients with chronic renal disease
24. Acute renal haemodynamic effects of angiotensin converting enzyme inhibition in diabetic hyperfiltration: The role of kinins
25. Contrasting renal effects of chronic administrations of enalapril and losartan on one-kidney, one clip hypertensive rats
26. World Health Organization-International Society of Hypertension guidelines for the management of hypertension
27. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure
28. British Hypertension Society guidelines for hypertension management 1999: Summary
29. Effect of lisinopril on progression of retinopathy in people with type 1 diabetes
30. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy